Back to search results

Study of Neoadjuvant Enfortumab Vedotin and Pembrolizumab in Upper Tract Urothelial Cancer

Abroad (travel likely)RecruitingPHASE2

Conditions

Urothelial Carcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States

    Contact: Study coordinator (Irene Tsung, M.D.) · itsung@umich.edu · 734-936-4385
    Contact: Principal Investigator (Irene Tsung, MD)

  • Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States

    Contact: Study coordinator (Elizabeth Plimack) · elizabeth.plimack@fccc.edu · 215-214-3925
Study leads

  • Irene Tsung

    Principal Investigator

    University of Michigan

View source on ClinicalTrials.gov(opens in a new tab)